PT347 Christopher Koddermann Rescheduling Psilocybin, Patents and IP, and The Entourage Effect
In this episode, Joe interviews Christopher Koddermann: Co-Founder of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI). He discusses patents, IP, and what needs to be done to reschedule psilocybin.\xa0
www.psychedelicstoday.com